Friday, February 14, 2020

Is there too much localism or not enough in our metropolitan areas Essay

Is there too much localism or not enough in our metropolitan areas today - Essay Example Particularly, the government as representative of the people ought to offer solutions to the problems that are facing its people. As such, the question as to the necessary policy concerning localism and implementation of the same will be featured in this paper. It is hard for some people to make out the difference between Localism and which concepts are involved in the metropolitan area governance. Localism is the belief on the existing system of a greater number of fairly small governments, wielding authority over such serious issues as land use guideline, local levying, and the financial support of the municipal services that ought to be preserved. Regionalism, on the other hand, seems to connote centralization and against the decentralization represented by the localism. America is dominated by metropolitan areas. Regionalism does not only oppose regionalism, but it is localism regional extension. Localism may also be based on the set of row as to the function of the local governments in endorsing the governmental efficiency, democracy and the public (Tam et al., 2002). In the modern metropolitan areas, economic, social and ecological local areas are regularly prevalent. The concerns on the efficiency, democracy and the community should lead to a shift in power from the existing localities and delegate it to the new processes, structures or organization that can support the decision making on behalf of the area. It can, therefore, be concluded that regionalism is the localism of the metropolitan regions. A localism is also a means of protecting the interests of the people who get benefits from the existing government structures (Gregg, 2003). Localism involves the shift of the power from the government to the local governments. The transformation is not only economic, but also social in nature. Localism makes people appreciate and identify with their new neighborhood and their

Saturday, February 1, 2020

Clinical study report for plavix Case Example | Topics and Well Written Essays - 3750 words

Clinical report for plavix - Case Study Example at least an episode of atherothrombotic event like heart disease, stroke as well as those diagnosed with peripheral arterial diseases characterized by problems with blood flowing into arteries especially in the leg region. This drug is also prescribed for patients diagnosed with acute coronary syndrome (ACS) and those with arterial fibrillation (AF); characterized by fast and irregular heartbeats (Dickie, Jennifer, and Lesley 34). Platelets are responsible for the clotting of blood whenever it is necessary for example, when one has a cut and in doing so prevents father bleeding and hemorrhage. In the event that arteries are narrowed by plagues, the body reacts by aggregating together and they may rapture and further increase narrowing of these vessels, which is, likely to increase the chance of heart attack, stroke and other circulatory disorders. This drug acts by reducing the chances of these occurrences by preventing the coagulation in the first place. Plavix acts by irreversibly binding to the P2Y12 receptors on platelets and preventing Adenosine diphosphate (ADP) from activating platelets, which form clots. Drug belongs to the group of drugs called P2Y12 inhibitors and is similar to the drug Ticlopidine (Ticlid) in its chemical structure and mechanism of action. The only difference is that Clopidogrel bisulfates do not cause serious decline in the white blood cell count as seen in patients on Ticlopidine hence there is no need for regular tests to determine white blood cell counts. Plavix is used to prevent the risk of heart disease and stroke in patients who have had a recent episode of heart attack, stroke and narrowed arteries as well as those suffering from peripheral vascular disease characterized by pain in the leg, which could be disabling. The US Food and Drug Association (FDA) approved this drug in 1997. This drug is used in prevention of atherothrombotic events like myocardial infarction (MI), Stroke and vascular death in patients with